Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent

NCT01308229 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Disease

Interventions

DEVICE: Nile PAX® paclitaxel-eluting coronary stent

Sponsor

MINVASYS